Clinical Trial Research
AVI BioPharma Announces 2006 Fourth Quarter and Full Year Financial Results
Published in Drug Week, March 30th, 2007
The net loss for the fourth quarter of 2006 was $8.3 million, or $0.16 per share, compared with a net loss for the fourth quarter of 2005 of $4.6 million, or $0.10 per share. Results for the fourth quarter of 2006 include non-cash stock-based compensation expenses of $935,000 recognized in accordance with SFAS 123R. Results for the fourth quarter of 2005 do not include SFAS 123R compensation expenses because SFAS 123R is effective beginning January 1, 2006. Revenues for the three months ended December 31, 2006 were $18,000, down from $1.4 million in the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2007-03-30)
More Articles from Drug Week
- Allergies
FDA Requests Label Change for All Sleep Disorder Drug Products - Alzheimer Disease
Computer predicts wishes of incapacitated patients better than family or loved ones - Anesthesia
Cocoa 'vitamin' health benefits could outshine penicillin - Angiogenesis
Two Novel Biologics Studied for Multiple Myeloma - Asthma
Safe Drug Compounding Act of 2007 Wins Favor with Consumer Health Alliance for Safe Medication - Behavior
Middle-Aged Adults Most Likely to Use Complementary Medicine - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
